Prevalence of metabolic syndrome in schoolchildren and adolescents in Turkey: a population-based study.

J Pediatr Endocrinol Metab

Division of Endocrinology and Diabetes, Department of Pediatrics, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.

Published: August 2009

Aim: To determine prevalence of the metabolic syndrome (MS) in the pediatric population.

Methods: We studied 2,491 schoolchildren randomly selected aged 10-19 years using a multistage, stratified sampling design. Obese and overweight participants were called for further investigation (n = 456). Of these, 310 participants underwent OGTT. MS was defined according to IDF, NCEP and modified WHO guidelines.

Results: The prevalence of obesity and overweight were 6.8% and 11.5%, respectively. While MS was found in 2.3% of the total population according to IDF guidelines, its prevalence was increased among overweight and obese individuals. MS prevalence was similar by both IDF and NCEP definitions but higher according to WHO definition. Individuals with MS were consistent by both IDF and NCEP definitions (sensitivity = 100%, specificity = 99%, positive predictive value = 95.2%). IDF and WHO defined different individuals as having MS (sensitivity = 67.5%, specificity = 90%, positive predictive value = 67.5%).

Conclusions: Although not as high as in developed countries, MS prevalence determined in schoolchildren and adolescents in Turkey warrants preventive measures. MS diagnosis in one of every three obese children shows that MS is an important public health problem in Turkey as well.

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem.2009.22.8.703DOI Listing

Publication Analysis

Top Keywords

idf ncep
12
prevalence metabolic
8
metabolic syndrome
8
schoolchildren adolescents
8
adolescents turkey
8
ncep definitions
8
positive predictive
8
prevalence
6
idf
5
syndrome schoolchildren
4

Similar Publications

Polycyclic aromatic hydrocarbons (PAHs) are an organic chemical family produced during incomplete combustion of organic materials. Besides, PAHs are associated with different detrimental health effects. Therefore, this research was aimed to assess the association between PAHs exposure, metabolic syndrome (MetS) prevalence, and cardiovascular risk in a Mexican population.

View Article and Find Full Text PDF

Introduction: The prevalence of metabolic syndrome among type 2 diabetes mellitus patients was inconsistent in Ethiopia. Therefore, we aimed to pool the prevalence of metabolic syndrome among type 2 diabetes mellitus patients using a systematic review and meta-analysis.

Methods: PubMed, EMBASE, and Cochrane Library databases were systematically searched for relevant articles from January 2023 to January 2024.

View Article and Find Full Text PDF

Background: Oxidative stress is a key contributor to the development of chronic kidney disease (CKD) in individuals with metabolic syndrome (MetS). The oxidative balance score (OBS) is an emerging composite assessment tool for dietary and lifestyle oxidative balance. We aimed to explore the association of OBS with CKD prevalence in MetS in this national cross-sectional analysis.

View Article and Find Full Text PDF

Background: Metabolic syndrome (MetS), a cluster of metabolic dysregulations indicative of increased cardiometabolic risk is on the rise in Sub-Saharan Africa. The study aimed to determine the prevalence of MetS and its components, among corporate employees in Kampala, Uganda.

Methods: A cross-sectional survey was undertaken among 408 adults who were employees from seven corporate companies in Kampala, using the WHO STEPwise NCD screening approach.

View Article and Find Full Text PDF

Aims/hypothesis: Metabolic abnormalities such as central obesity, insulin resistance, dyslipidaemia and hypertension, often referred to as 'the metabolic syndrome' (or 'combined metabolic abnormalities'), are increasingly being identified in people living with type 1 diabetes, accelerating the risk for CVD. As a result, in recent years, treatment in people living with type 1 diabetes has shifted to improving overall metabolic health rather than glucose control alone. In Belgium, diabetes care for people living with type 1 diabetes is centrally organised.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!